BBraun Medical Inc. issues voluntary nationwide recall of lot H3A744, 1 gram Cefepime

0

#IVTEAM #Intravenous products: FDA report “B. Braun Medical Inc. (B.Braun) is voluntarily recalling one lot of 1g Cefepime for Injection USP and Dextrose Injection USP (Lot H3A744, catalog 3193-11) to the consumer level. The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit. B.Braun has not received any reports of adverse events related to this lot to date.”

Main page

Share.

Comments are closed.